Adverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort study.
Priyanshu NainNickolas StabelliniOmar M MakramJohnathan RastSandeep YerraguntlaGaurav GopuAditya BhaveLakshya SethVraj PatelStephanie JiangSarah MalikAhmed ShetewiAlberto J MonteroJennifer CullenArchana M AgarwalXiaoling WangBonnie KyLauren A BaldassarreNeal L WeintraubRyan A HarrisAvirup GuhaPublished in: JNCI cancer spectrum (2024)
The role of social determinants of health (SDOH) in controlling hypertension (HTN) in cancer patients is unknown. We hypothesize that high SDOH scores correlate with uncontrolled HTN in hypertensive cancer patients. In our prospective study, patients completed the Protocol for Responding to & Assessing Patients' Assets, Risks & Experiences questionnaire. After integrating home and clinic blood pressure readings, uncontrolled HTN was defined as systolic blood pressure greater than or equal to 140 mm Hg and/or diastolic blood pressure greater than or equal to 90 mm Hg. Using Cox regression, we analyzed the impact of SDOH on HTN control, adjusting for relevant factors. The study involved 318 participants (median age 66.4, median follow-up 166 days, SDOH score 6.5 ± 3.2), with stress, educational insecurity, and social isolation as prevalent adverse SDOH. High SDOH scores led to 77% increased risk of uncontrolled HTN (adjusted hazards ratio = 1.77; 95% confidence interval = 1.10 to 2.83, P = .018). Urban residents with high SDOH scores were at an even greater risk. Identifying SDOH and mitigating underlying factors may help control HTN, the most typical disease process treated in all cardio-oncology clinics.
Keyphrases
- blood pressure
- end stage renal disease
- hypertensive patients
- healthcare
- heart rate
- ejection fraction
- mental health
- newly diagnosed
- chronic kidney disease
- public health
- primary care
- heart failure
- peritoneal dialysis
- randomized controlled trial
- palliative care
- type diabetes
- left ventricular
- prognostic factors
- climate change
- fluorescent probe
- patient reported outcomes
- cross sectional
- single molecule
- skeletal muscle
- atrial fibrillation
- aqueous solution